Objective:
The primary goal of the study was to determine whether taking two different formulations of a commercially available encapsulated juice powder concentrate could improve endothelial function — a risk factor for type 2 diabetes and cardiovascular disease - in people with metabolic syndrome compared to placebo.
PubMed link:
https://pubmed.ncbi.nlm.nih.gov/21714890/